Pharmaceutical companies can confidentially analyze de-identified EMR histories for observational studies, synthetic external control arms, finding patients who fit trial criteria, or other real world data use cases
How it works
Clinically Innovative Partnerships For Pharmaceutical Sponsors
How we work before we are contracted for a specific protocol
1
Our in-house physicians build data dictionaries specializing our algorithms to disease types
2
We work synergetically with trial site IRB’s to keep all data queries within their healthcare systems firewalls in a regulatory compliant manner. Only trial site research teams are able to identify their own patients.
3
Our NLP extracts clinical datapoints relevant for clinical research protocols
How pharma sponsors can contract with us
1
Mutual CDA’s signed
2
We scope your protocol for patient population size, complexity of criteria and data point availability
3
We provide you with a proposed plan of action to match de-identified patients to trials, along with timeline and cost
Once we are working with pharma sponsors on a live contract
1
We work with healthcare systems within our partner network and/or pharma’s trial site network for approvals, compliance, and observational clinical study data
2
Our studies take the purpose of one of the following use cases for specific disease indications:
Synapsis
Analyze Biomarkers over time
Research
Create synthetic control arms
Patient Predict
Enrollment Allocations
Patient Finder
Pre-qualify patients on more than 80% of your most complex protocol criteria
